The Different Dose-Volume Effects of Normal Tissue Complication Probability Using LASSO for Acute Small-Bowel Toxicity during Radiotherapy in Gynecological Patients with or without Prior Abdominal Surgery
Open Access
- 1 January 2014
- journal article
- clinical trial
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-9
Abstract
Purpose. To develop normal tissue complication probability (NTCP) model with least absolute shrinkage and selection operator (LASSO) to analyze dose-volume effects that influence the incidence of acute diarrhea among gynecological patients with/without prior abdominal surgery.Methods and Materials. Ninety-five patients receiving gynecologic radiotherapy (RT) were enrolled. The endpoint was defined as the grade 2+acute diarrhea toxicity during treatment. We obtained the range of small-bowel volume in V4 Gy to V40 Gy of dose.Results. The number of patients experiencing grade 2+acute diarrhea toxicity was 23/61 (38%) in the group without abdominal surgery (group 0) and 17/34 (50%) patients with abdominal surgery (group 1). The most significant predictor was found for the logistic NTCP model with V16 Gy as the cutoff dose for group 0 and V40 Gy for group 1. Logistic regression NTCP model parameters were TV10≈ 290 cc for V16 Gy and TV10≈ 75 cc for V40 Gy, respectively.Conclusion. To keep the incidence of grade 2+acute small-bowel toxicity below 10%, we suggest that small-bowel volume above the prescription dose (V16 Gy) should be held to <290 cc for patients without abdominal surgery, and the prescription dose (V40 Gy) should be maintained <75 cc for patients with abdominal surgery.Keywords
Funding Information
- National Science Council (NSC-101-2221-E-151-007-MY3, NSC-102-2221-E-182A-002, CMRPG871101)
- National Science Council (NSC-101-2221-E-151-007-MY3, NSC-102-2221-E-182A-002, CMRPG871101)
- Chang-Gung Medical Research Project (NSC-101-2221-E-151-007-MY3, NSC-102-2221-E-182A-002, CMRPG871101)
This publication has 33 references indexed in Scilit:
- Effect of different treatment plans on irradiated small-bowel volume in gynecologic patients undergoing whole-pelvic irradiationJournal of Radiation Research, 2013
- Dose–response analysis of parotid gland function: What is the best measure of xerostomia?Radiotherapy and Oncology, 2013
- Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapyRadiotherapy and Oncology, 2013
- A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: A gynecologic oncology group studyGynecologic Oncology, 2012
- Dose–volume effects for normal tissues in external radiotherapy: PelvisRadiotherapy and Oncology, 2009
- Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose–based and dose–volume–based normal tissue complication probability modelsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Multivariable modeling of radiotherapy outcomes, including dose–volume and clinical factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Least angle regressionThe Annals of Statistics, 2004
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Complication Probability as Assessed from Dose-Volume HistogramsRadiation Research, 1985